ICP
LLY icon

Ironvine Capital Partners’s Eli Lilly LLY Stock Holding History

Ironvine Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,525
Closed -$273K – 76
2018
Q1 		$273K Sell
3,525
-1,200
-25% -$96.6K 0.07% 80
2017
Q4 		$399K Buy
+4,725
New +$402K 0.12% 77

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ironvine Capital Partners's LLY Position: Q2 2018 in Review

Ironvine Capital Partners sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 3,525 shares — an estimated $273K sold.

Ironvine Capital Partners first reported a position in LLY in Q4 2017 and held it in 2 quarters. The position peaked at $399K in Q4 2017. 1,369 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Ironvine Capital Partners reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Ironvine Capital Partners sold 3,525 Eli Lilly shares in Q2 2018, an estimated $273K.
  • Ironvine Capital Partners first reported a position in Eli Lilly in Q4 2017 and held it in 2 quarters.
  • Ironvine Capital Partners's Eli Lilly position peaked at $399K in Q4 2017.
  • 1,369 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Ironvine Capital Partners's 13F filing for Q2 2018, filed 26 Jul 2018.